Sage Journals: Discover world-class research

Free access

Case report

First published 2016-1

Hyperuricemia in 2 Patients Receiving Palbociclib for Breast Cancer

David J. Bromberg, Mauricio Valenzuela, Sowmya Nanjappa [...]

Cancer Control

Retricted access

Case report

First published 2019-4

Verapamil as a culprit of palbociclib toxicity

Jasmine L Gowarty, Jon D Herrington

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-12

Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive,HER2-Negative Metastatic/Recurrent Breast Cancer

Makiko Go, Michio Kimura, Shiori Yamada [...]

Journal of Pharmacy Practice

Open access

Review article

First published 2018

Updates on managing advanced breast cancer with palbociclib combination therapy

Teresa M. McShane, Thomas A. Wolfe, Joanne C. Ryan

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2023-6

Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib

Christina Watts, Karin Nadori

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2018

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer

Marc Thill, Marcus Schmidt

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026

Persistence to palbociclib treatment in HR+/HER2– breast cancer patients: A real-world study

Alejandro Valcuende-Rosique, Dolores Rosique-Robles, Aina Iranzo Sabater [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan—The KBCOG-14 Study

Nina Odan, Yuichiro Kikawa, Hajime Matsumoto [...]

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2024

Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system

Jun Shen, Pingli Luo, Jianmei Xu

Therapeutic Advances in Drug Safety

Open access

Brief report

First published 2026

Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer

Chanhyun Park, Kiyoung Kim, Nora B. Abifaraj [...]

Therapeutic Advances in Drug Safety

Search results